HIMS Plunges 2.95% with $1.26 Billion Volume Ranks 83rd in Liquidity Amid Regulatory Scrutiny

On Sept. 23, 2025, Hims & Hers Health (HIMS) closed down 2.95% with a trading volume of $1.26 billion, ranking it 83rd in terms of liquidity among U.S. equities. The decline came amid mixed investor sentiment toward digital health platforms following regulatory scrutiny and evolving market dynamics in the telehealth sector.

Analysts noted that the stock's performance reflected broader concerns about the sustainability of growth in the direct-to-consumer healthcare space. Recent developments highlighted risks related to pricing pressures and competitive threats from established players expanding into telemedicine services. Despite a recent product launch aimed at broadening its service offerings, the stock failed to attract significant institutional buying interest.

Backtesting of a hypothetical strategy involving daily rebalancing of the top 500 cash-volume stocks from Jan. 1, 2022, to the present remains pending due to platform limitations in multi-asset portfolio simulations. The proposed approach would require either narrowing the scope to a static ticker list or utilizing a proxy instrument until full portfolio engine capabilities are implemented. Key parameters such as market universe and transaction costs remain to be finalized before the test can proceed.